Aref Al-Kali

Hematologist focused on myeloid diseases. views are mine

[Aref Al-Kali @AlkaliDr]

Comparison of different models in #CCUS
⭐️ models perform differently based on endpoint
⭐️ CCRS/CHRS do well for progression to MN
⭐️ models perform differently to predict MDS vs CMML vs AML
⭐️ to predict OS modified IPSS-m did the best

⁦#ccus https://t.co/CRSwUYknlE

[Aref Al-Kali @AlkaliDr]

#Bezuclastinib in AdvSM is active in decreasing marrow mast cells, tryptase and KIT VAF. #Eha2026

[Aref Al-Kali @AlkaliDr]

#INCA033989 as monotherapy or combo with JAK2i in pts with #CALRm MF. Very encouraging results. #eha2026

[Aref Al-Kali @AlkaliDr]

#LUSP vs PBO as add-on to JAKi in pts with MF requiring blood transfusions. #Eha2026

[Aref Al-Kali @AlkaliDr]

@MayoCancerCare experience using outpatient #melphelan conditioning presented by our fellow Dr #Mathias_Palmer. #EHA2026

[Aref Al-Kali @AlkaliDr]

Good to see you all @mpdrc @Dr_AmerZeidan @tariqkewan . #EHA2026

[Aref Al-Kali @AlkaliDr]

A great delicious end of a conference day 🍲 🥤 with company. #eha2026

#stockholm
#midan

[Aref Al-Kali @AlkaliDr]

#ofirnoflast in LR-MDS shows improvement in Hg PLT and ANC. #Eha2026

[Aref Al-Kali @AlkaliDr]

#Maxilus study of max dose of LUSP in LR-MDS. #EHA2026

[Aref Al-Kali @AlkaliDr]

#phenotype_score of #p53m in #MDS. Great work and novel data. #EHA2026

[Aref Al-Kali @AlkaliDr]

#Paloma study in #HR_MDS. CPX351 had better EFS but similar OS to 7+3 or AZA. Interim analysis. #EHA2026

[Aref Al-Kali @AlkaliDr]

Great meeting colleagues from #Doha #Qatar during #EHA2026. Prof. #Cherif. @MayoCancerCare @SidraMedicine

[Joshua Zeidner MD @LeukDocJZ]

Super proud of @beatalleukemia for delivering a fantastic presentation of the OPTI-AML data showing that Aza/Ven-14 is NOT equivalent to Aza/Ven-28 days at least for induction cycles 1-2. Highly impactful study from our BEAT AML team @bcutd_research

[Aref Al-Kali @AlkaliDr]

@TalhaBadarMD @jorgecortesmd I now feel jealous with this amazing team and mentors ❤️

[Aref Al-Kali @AlkaliDr]

Our fellows presenting at #EHA2026. @MayoHemeOnc 👏 👏 Drs #Palmer @HadilZureigat @kimball_md

[Aref Al-Kali @AlkaliDr]

Always 😊 to see my friend @Ramikomrokji at #EHA2026

[Aref Al-Kali @AlkaliDr]

Location if interested

https://t.co/irbR3hR3y3

[Aref Al-Kali @AlkaliDr]

Attending @FIFAWorldCup live from Stockholm during #EHA2026 ⚽️ ⚽️ . 🇲🇽 Vs 🇿🇦

[Aref Al-Kali @AlkaliDr]

#Aza_ven as salvage therapy for molecular relapse in #NPM1m #AML. #EHA2026

[Aref Al-Kali @AlkaliDr]

Very important randomized study of AV 28 vs 14 days in #AML. A very important study with more questions raised. 👏 #eha2026 #BCU

[Aref Al-Kali @AlkaliDr]

#VAA vs #VA in FL-AML not fit for intensive chemo. #EHA2026